BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 36380816)

  • 1. Circular RNAs: New layer of complexity evading breast cancer heterogeneity.
    Dawoud A; Ihab Zakaria Z; Hisham Rashwan H; Braoudaki M; Youness RA
    Noncoding RNA Res; 2023 Mar; 8(1):60-74. PubMed ID: 36380816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNAs as Potential Biomarkers in Breast Cancer.
    De Palma FDE; Salvatore F; Pol JG; Kroemer G; Maiuri MC
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNAs: Their Role in the Pathogenesis and Orchestration of Breast Cancer.
    He X; Xu T; Hu W; Tan Y; Wang D; Wang Y; Zhao C; Yi Y; Xiong M; Lv W; Wu M; Li X; Wu Y; Zhang Q
    Front Cell Dev Biol; 2021; 9():647736. PubMed ID: 33777954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNAs as biomarkers and therapeutic targets in cancer.
    Beilerli A; Gareev I; Beylerli O; Yang G; Pavlov V; Aliev G; Ahmad A
    Semin Cancer Biol; 2022 Aug; 83():242-252. PubMed ID: 33434640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Derived Exosomal Non-Coding RNAs: The Emerging Mechanisms and Potential Clinical Applications in Breast Cancer.
    Yi Y; Wu M; Zeng H; Hu W; Zhao C; Xiong M; Lv W; Deng P; Zhang Q; Wu Y
    Front Oncol; 2021; 11():738945. PubMed ID: 34707990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal circular RNAs: New player in breast cancer progression and therapeutic targets.
    Hussen BM; Mohamadtahr S; Abdullah SR; Hidayat HJ; Rasul MF; Hama Faraj GS; Ghafouri-Fard S; Taheri M; Khayamzadeh M; Jamali E
    Front Genet; 2023; 14():1126944. PubMed ID: 36926585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Non-Coding RNAs in Breast Cancer Drug Resistance.
    Tian JH; Liu SH; Yu CY; Wu LG; Wang LB
    Front Oncol; 2021; 11():702082. PubMed ID: 34589423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging roles of circular RNAs in ovarian cancer.
    Yang X; Mei J; Wang H; Gu D; Ding J; Liu C
    Cancer Cell Int; 2020; 20():265. PubMed ID: 32587475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNAs: novel regulators of resistance to systemic treatments in breast cancer.
    Guo XQ; Hua YM
    Neoplasma; 2022 Sep; 69(5):1019-1028. PubMed ID: 35900318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer.
    Tian T; Zhao Y; Zheng J; Jin S; Liu Z; Wang T
    Mol Ther Nucleic Acids; 2021 Dec; 26():63-80. PubMed ID: 34513294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircRNAs: Emerging Bladder Cancer Biomarkers and Targets.
    Liang Z; Guo W; Fang S; Zhang Y; Lu L; Xu W; Qian H
    Front Oncol; 2020; 10():606485. PubMed ID: 33489913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer.
    Li C; Zhang L; Meng G; Wang Q; Lv X; Zhang J; Li J
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):2875-2889. PubMed ID: 31630262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNAs: Biogenesis, Function, and a Role as Possible Cancer Biomarkers.
    Bolha L; Ravnik-Glavač M; Glavač D
    Int J Genomics; 2017; 2017():6218353. PubMed ID: 29349062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current research on circular RNAs and their potential clinical implications in breast cancer.
    Liu D; Fang L
    Cancer Biol Med; 2021 May; 18(3):635-48. PubMed ID: 34018386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNAs and Hepatocellular Carcinoma: New Epigenetic Players With Diagnostic and Prognostic Roles.
    Aishanjiang K; Wei XD; Fu Y; Lin X; Ma Y; Le J; Han Q; Wang X; Kong X; Gu J; Wu H
    Front Oncol; 2021; 11():653717. PubMed ID: 33959506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent Research Progress on CircRNA in Hematological Malignancies--Review].
    Bai X; Chen XF; Li ZY; Wang M; Li JJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):927-930. PubMed ID: 37356963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNAs function as competing endogenous RNAs in multiple types of cancer.
    Ji Q; Zhang C; Sun X; Li Q
    Oncol Lett; 2018 Jan; 15(1):23-30. PubMed ID: 29387208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of circRNAs and their clinical significance in human cancers.
    Qian L; Yu S; Chen Z; Meng Z; Huang S; Wang P
    Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):247-260. PubMed ID: 29928954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia.
    Rahmati A; Mafi A; Soleymani F; Babaei Aghdam Z; Masihipour N; Ghezelbash B; Asemi R; Aschner M; Vakili O; Homayoonfal M; Asemi Z; Sharifi M; Azadi A; Mirzaei H; Aghadavod E
    Front Oncol; 2023; 13():1149187. PubMed ID: 37124518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of circRNAs in hematological malignancies.
    Deng F; Zhang C; Lu T; Liao EJ; Huang H; Wei S
    Biomark Res; 2022 Jul; 10(1):50. PubMed ID: 35840998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.